Publications by authors named "Stephen Hauser"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

38,759

Total Likes

613

Extended Reach

145,069

Social Features

22
R
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
Kathleen Hawker, Paul O'Connor, Mark S Freedman, Peter A Calabresi, Jack Antel, Jack Simon, Stephen Hauser, Emmanuelle Waubant, Timothy Vollmer, Hillel Panitch

Ann Neurol· October 2009

Videos about Article: user user

2 1 19 2 4

View All Article and Social Media Activity
C
Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis.
Tjalf Ziemssen, Mark S Freedman, Amit Bar-Or, Xavier Montalban, Charlotte E Teunissen, Stephen L Hauser

Mult Scler· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-year safety and efficacy outcomes with first-line ofatumumab in recently diagnosed treatment-naive patients with relapsing multiple sclerosis.
Stephen L Hauser, Mark S Freedman, Jin Nakahara, David Paling, Jérôme de Seze

Mult Scler Relat Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.
Ahmed Abdelhak, Franziska Bachhuber, Kiarra Ning, Pascal Benkert, W John Boscardin, Stephen L Hauser

J Neurol Neurosurg Psychiatry· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis.
Simone Sacco, Nico Papinutto, Vinicius A Schoeps, Shuiting Cheng, William A Stern, Stephen L Hauser

Ann Neurol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Safety and Efficacy Outcomes with Ofatumumab in Patients with Relapsing Multiple Sclerosis.
Stephen L Hauser, Jeffrey A Cohen, Jérôme de Sèze, Sven G Meuth, Paul S Giacomini

Neurol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelin injury precedes axonal injury and symptomatic onset in multiple sclerosis.
Ahmed Abdelhak, Gabriel Cerono, Fahime Sheikhzadeh, Adil Harroud, Kiarra Ning, Stephen L Hauser

Nat Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the impact of age on neurodegeneration after optic neuritis in multiple sclerosis using optical coherence tomography.
Henriette Km Reinsberg, Frederike C Oertel, Daniel Casillas, Gelsomina Kaufhold, Shivany Condor Montes, Stephen L Hauser

Mult Scler· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence.
Gabriel Cerono, Bruce A C Cree, Stephen L Hauser, Sergio E Baranzini

Ann Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond.
Joseph J Sabatino, Bruce A C Cree, Stephen L Hauser

Ann Neurol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis.
Brian C Zhang, Tilman Schneider-Hohendorf, Rebecca Elyanow, Beatrice Pignolet, Simon Falk, Stephen L Hauser

EBioMedicine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple Sclerosis.
Alice G Willison, Ramona Hagler, Margit Weise, Saskia Elben, Niklas Huntemann, Stephen L Hauser

Cells· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Menopause With Functional Outcomes and Disease Biomarkers in Women With Multiple Sclerosis.
Hannah E Silverman, Alan Bostrom, Alyssa N Nylander, Amit Akula, Ann A Lazar, Stephen L Hauser

Neurology· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programming tissue-sensing T cells that deliver therapies to the brain.
Milos S Simic, Payal B Watchmaker, Sasha Gupta, Yuan Wang, Sharon A Sagan, Stephen L Hauser

Science· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen specificity of clonally-enriched CD8+ T cells in multiple sclerosis.
Kristen Mittl, Fumie Hayashi, Ravi Dandekar, Ryan D Schubert, Josiah Gerdts, Stephen L Hauser

bioRxiv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trials.
Tobias Derfuss, Robert Bermel, Chien-Ju Lin, Stephen L Hauser, Ludwig Kappos

Ther Adv Neurol Disord· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.
Feng Mei, Stephen P J Fancy, Yun-An A Shen, Jianqin Niu, Chao Zhao, Stephen L Hauser

Nat Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency.
John V Pluvinage, Thomas Ngo, Camille Fouassier, Maura McDonagh, Brandon B Holmes, Stephen L Hauser

Sci Transl Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An autoantibody signature predictive for multiple sclerosis.
Colin R Zamecnik, Gavin M Sowa, Ahmed Abdelhak, Ravi Dandekar, Rebecca D Bair, Stephen L Hauser

Nat Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis.
Tanuja Chitnis, Ferhan Qureshi, Victor M Gehman, Michael Becich, Riley Bove, Stephen L Hauser

Nat Commun· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synaptic injury in the inner plexiform layer of the retina is associated with progression in multiple sclerosis.
Christian Cordano, Sebastian Werneburg, Ahmed Abdelhak, Daniel J Bennett, Alexandra Beaudry-Richard, Stephen L Hauser

Cell Rep Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocrelizumab exposure in relapsing-remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension.
Ludwig Kappos, Anthony Traboulsee, David K B Li, Amit Bar-Or, Frederik Barkhof, Stephen L Hauser

J Neurol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silencing Immune Dialogue in Multiple Sclerosis.
Stephen L Hauser

N Engl J Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcome parameters and disability worsening in progressive multiple sclerosis.
Ahmed Abdelhak, Kai Antweiler, Markus C Kowarik, Makbule Senel, Joachim Havla, Stephen L Hauser

Mult Scler Relat Disord· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis.
Ahmed Abdelhak, Pascal Benkert, Sabine Schaedelin, W John Boscardin, Christian Cordano, Stephen L Hauser

JAMA Neurol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-resolution DNA methylation screening of the major histocompatibility complex in multiple sclerosis.
Qin Ma, Danillo G Augusto, Gonzalo Montero-Martin, Stacy J Caillier, Kazutoyo Osoegawa, Stephen L Hauser

Front Neurol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis